Literature DB >> 17212860

Lessons learned from a population-based chlamydia screening pilot.

Hannelore M Götz1, Jan E A M van Bergen, Irene K Veldhuijzen, Christian J P A Hoebe, Jan Broer, A J J Coenen, F de Groot, M J C Verhooren, D T van Schaik, Jan H Richardus.   

Abstract

We evaluated process organization and response optimization in a home-based Chlamydia trachomatis (Ct) screening project in the Netherlands among 15- to 29-year-old women and men. The method used was computer-supported data flow, from population sampling to informing participants of the result. A new test kit or a letter reminded non-respondents after six weeks. Fifteen-year olds required parental consent. Urine arrived at the laboratory within 29 days from invitation, and four (1-11) days after collection, indicating good specimen quality. Test kits had a higher response than letters (15 versus 10%). Response in 15-year olds was 33%; with 2% Ct infected sexually active 15 year olds. In Conclusion, purpose made computer software is essential for an efficient screening programme. Sending urine by mail does not impair diagnostics. Reminders are necessary and effective after four weeks. Necessary parental consent for under 16-year olds should not be a deterrent to offer Ct screening to this age group.

Entities:  

Mesh:

Year:  2006        PMID: 17212860     DOI: 10.1258/095646206779307577

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  8 in total

Review 1.  Home versus clinic-based specimen collection for Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Anna S Graseck; Shirley L Shih; Jeffrey F Peipert
Journal:  Expert Rev Anti Infect Ther       Date:  2011-02       Impact factor: 5.091

Review 2.  Screening for sexually transmitted infections at home or in the clinic?

Authors:  Shirley L Shih; Anna S Graseck; Gina M Secura; Jeffrey F Peipert
Journal:  Curr Opin Infect Dis       Date:  2011-02       Impact factor: 4.915

3.  Influence of temperature, medium, and storage duration on Chlamydia trachomatis DNA detection by PCR.

Authors:  Laura van Dommelen; Petra F G Wolffs; Frank H van Tiel; Nicole Dukers; Selma B Herngreen; Cathrien A Bruggeman; Christian J P A Hoebe
Journal:  J Clin Microbiol       Date:  2012-12-19       Impact factor: 5.948

4.  Cultural tailoring for the promotion of hepatitis B screening in Turkish Dutch: a protocol for a randomized controlled trial.

Authors:  Ytje J J van der Veen; Onno de Zwart; Johan Mackenbach; Jan Hendrik Richardus
Journal:  BMC Public Health       Date:  2010-11-05       Impact factor: 3.295

5.  Keeping participants on board: increasing uptake by automated respondent reminders in an Internet-based chlamydia screening in the Netherlands.

Authors:  Nynke F B Dokkum; Rik H Koekenbier; Ingrid V F van den Broek; Jan E A M van Bergen; Elfi E H G Brouwers; Johannes S A Fennema; Hannelore M Götz; Christian J P A Hoebe; Lydia L Pars; Sander M van Ravesteijn; Eline L M Op de Coul
Journal:  BMC Public Health       Date:  2012-03-09       Impact factor: 3.295

Review 6.  Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections.

Authors:  Luisa Fajardo-Bernal; Johanna Aponte-Gonzalez; Patrick Vigil; Edith Angel-Müller; Carlos Rincon; Hernando G Gaitán; Nicola Low
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29

Review 7.  Home-based chlamydia and gonorrhoea screening: a systematic review of strategies and outcomes.

Authors:  Muhammad S Jamil; Jane S Hocking; Heidi M Bauer; Hammad Ali; Handan Wand; Kirsty Smith; Jennifer Walker; Basil Donovan; John M Kaldor; Rebecca J Guy
Journal:  BMC Public Health       Date:  2013-03-04       Impact factor: 3.295

8.  Systematic screening with information and home sampling for genital Chlamydia trachomatis infections in young men and women in Norway: a randomized controlled trial.

Authors:  Hilde Kløvstad; Olav Natås; Aage Tverdal; Preben Aavitsland
Journal:  BMC Infect Dis       Date:  2013-01-23       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.